Dr. Richard A. Shlofmitz, MD

Dr. Shlofmitz practices at St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre.

Dr. Shlofmitz's NPI, 1730192709, was assigned on August 14, 2006. Dr. Shlofmitz graduated from New York University Grossman School of Medicine in 1980. Dr. Shlofmitz holds New York license 146488.

Dr. Shlofmitz's primary practice is St. Francis Hospital & Heart Center, at 100 Port Washington Boulevard, Roslyn, NY 11576 in Nassau County. The practice phone is (516) 562-6000.

Dr. Shlofmitz's primary practice is St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre. Dr. Shlofmitz is also affiliated with Stony Brook University Hospital. The medical group on file is Cardiac Interventional Group. Dmand AI also links Dr. Shlofmitz to 3 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shlofmitz practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Shlofmitz's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Shlofmitz is licensed in New York.

CMS data shows 5,583 Medicare services from Dr. Shlofmitz across 23 procedure codes in 2024, for 3,591 Medicare patients. Medicare paid $1,017,494 for them.

CMS counts 3,591 Medicare patients who saw Dr. Shlofmitz in 2024. The largest group is 75 to 84, with 1,563 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.27, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Shlofmitz's median patient age at 74, with 35% women.

In 2024, Dr. Shlofmitz wrote 11,714 Medicare Part D claims for 2,220 patients. 85% of them were for generic drugs. CMS names the drug for 11,266 of them, across 93 drugs with 11 or more claims each, at $2,007,386 in total drug cost. In 2023, CMS named 9,505 claims across 89 drugs.

Dr. Shlofmitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 508 procedures of coronary angioplasty and stenting by Dr. Shlofmitz, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 162 papers to Dr. Shlofmitz, published from 2011 to 2025. 2020 was the busiest year, with 15. The most frequent topics are Coronary Artery Disease, Percutaneous Coronary Intervention and Coronary Angiography. Dr. Shlofmitz has published most often in EuroIntervention. Dr. Shlofmitz's most frequent co-authors are Evan Scott Shlofmitz, DO, Allen Jeremias, MD and Michael S. Lee, MD.

Dmand AI links Dr. Shlofmitz to 9 clinical trials. 2 are still active or recruiting. Conditions studied include Coronary Artery Disease, Coronary Stenosis and Coronary Disease. Abbott Medical Devices sponsors the most, 3.

CMS Open Payments shows 270 general payments to Dr. Shlofmitz from 33 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. Cardiovascular Systems Inc. paid the most, $69,336.

Dr. Shlofmitz graduated from New York University Grossman School of Medicine in 1980.